SCHEMBL18661464

SCHEMBL18661464

COc1ccccc1-c1cccnc1Oc1cnc(C(F)(F)F)c(C)c1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.43
▸ PPP1CA P62136 1/20 0.43
▸ PDE10A Q9Y233 6/20 0.42
▸ TSHR P16473 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ DRD1 P21728 3/20 0.39
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ P2RY1 P47900 1/20 0.39
▸ ELANE P08246 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20394443 0.91 DRD1 (0.39) KMT2APPP1CAPDE10ADRD1L3MBTL1
SCHEMBL20406667 0.90 DRD1 (0.42) KMT2APPP1CAPDE10ADRD1
SCHEMBL20406168 0.90 PDE10A (0.47) KMT2APPP1CAPDE10ADRD1
SCHEMBL20406569 0.84 DRD1 (0.40) KMT2APPP1CAPDE10ADRD1SMN1; SMN2
SCHEMBL20406580 0.84 GPBAR1 (0.40) KMT2APPP1CAPDE10ADRD1
SCHEMBL18661456 0.84 PDE10A (0.42) PDE10ADRD1L3MBTL1LMNASMN1; SMN2
SCHEMBL18661462 0.83 GPBAR1 (0.39) KMT2APPP1CAPDE10ADRD1
SCHEMBL20394322 0.83 PDE10A (0.45) KMT2APPP1CAPDE10ATSHRHTT
SCHEMBL20406574 0.82 DRD1 (0.40) PDE10ADRD1
SCHEMBL20406584 0.82 GPBAR1 (0.41) PDE10ADRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3351533-B1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME KAKEN PHARMA CO LTD (JP) 2025-07-23 — — EP disclosed
US-10647675-B2 Biaryl derivative and medicine containing same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2020-05-12 — — US disclosed
US-10647675-B2 Biaryl derivative and medicine containing same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2020-05-12 — — US disclosed
US-20190055199-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2019-02-21 — — US disclosed
US-20190055199-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2019-02-21 — — US disclosed
EP-3351533-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME Kaken Pharmaceutical Co., Ltd. (JP) 2018-07-25 — — EP disclosed
EP-3351533-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME Kaken Pharmaceutical Co., Ltd. (JP) 2018-07-25 — — EP disclosed
WO-2017047602-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME 科研製薬株式会社 2017-03-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647675-B2 Biaryl derivative and medicine containing same MAN2B1, CBR3, MANBA KMT2A 544/4885PPP1CA 3336/4885PDE10A 4605/4885
US-20190055199-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME MAN2B1, CBR3, MANBA KMT2A 544/4885PPP1CA 3336/4885PDE10A 4605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback